Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
Clinical trial NCT05506488 · COMPLETED
Trial details
- NCT number
- NCT05506488
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2026-02-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.